Related Experiment Video
Updated: May 6, 2026

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery
Published on: November 5, 2019
Invasive meningococcal disease
Abstract:
Invasive meningococcal disease (IMD) is a major public health and continues to cause substantial mortality and morbidity. Serotype C is the most frequent in Brazil. The clinical spectrum of IMD is broad (meningitis, meningococcemia or both) and the clinical evolution may be unpredictable. Main features associated with mortality are: age higher than 50 years old, seizures, shock, and meningococcemia without meningitis. Blood cultures should be obtained immediately. Lumbar puncture can be performed without previous computed tomography scan (CT) in most cases. Clinical features can be useful to predic patients where an abnormal CT scan is likely. Cerebrospinal fluid (CSF) culture and Gram stain should always be required. Latex agglutination sensitivity is highly variable. Polymerase chain reaction is specially useful when other methods are negative or delayed. Usually ceftriaxone should not be delayed while awaiting CSF study or CT. Dexamethasone can be used in meningococcal meningitis. Early suspicion of IMD and antibiotic in primary care before hospitalization, rapid transportation to a hospital, and stabilization in an intensive-care unit has substantially reduced the case-fatality rate. Vaccines against serotypes A, C, W-135, and Y are available while vaccines against serotype B are expected.
Insights
Invasive meningococcal disease (IMD) poses significant health risks, particularly in Brazil due to Serotype C. Early suspicion, prompt antibiotic treatment, and intensive care are crucial for reducing mortality from this serious infection.
Area of Science:
- Infectious Diseases
- Public Health
- Clinical Medicine
Background:
- Invasive meningococcal disease (IMD) remains a significant global health concern, causing considerable mortality and morbidity.
- Serotype C is identified as the predominant strain in Brazil, highlighting regional epidemiological variations.
- The clinical presentation of IMD is diverse, ranging from meningitis to meningococcemia, with unpredictable outcomes.
Purpose of the Study:
- To outline the key clinical features and diagnostic approaches for invasive meningococcal disease.
- To identify prognostic indicators associated with mortality in IMD patients.
- To emphasize the importance of timely diagnosis and management strategies for improving patient outcomes.
Main Methods:
- Review of clinical features associated with mortality, including age, seizures, shock, and specific clinical presentations.
- Recommendations for immediate diagnostic procedures: blood cultures, lumbar puncture (CT scan optional prior), cerebrospinal fluid (CSF) analysis (Gram stain, culture).
- Evaluation of diagnostic test sensitivities (Latex agglutination, Polymerase Chain Reaction) and timely antibiotic administration (ceftriaxone, dexamethasone).
Main Results:
- Mortality in IMD is linked to older age (>50 years), seizures, shock, and meningococcemia without meningitis.
- CSF culture and Gram stain are essential; PCR offers utility when other methods are negative or delayed.
- Prompt administration of ceftriaxone, even before definitive diagnostic results, is recommended.
Conclusions:
- Early suspicion, pre-hospital antibiotic administration, rapid transport, and intensive care significantly reduce IMD case-fatality rates.
- Clinical assessment can guide the need for CT scans prior to lumbar puncture.
- Available vaccines target serotypes A, C, W-135, and Y, with B-specific vaccines anticipated.
Related Concept Videos
Bacterial Meningitis I: Introduction
Bacterial Meningitis II: Pathophysiology
Viral Meningitis
Arboviral Encephalitis
Encephalitis l: Introduction
Brain Abscess l: Introduction

